SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-323073
Filing Date
2019-12-26
Accepted
2019-12-26 08:01:03
Documents
2
Period of Report
2019-12-23
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d856972d8k.htm 8-K 31942
2 EX-3.1 d856972dex31.htm EX-3.1 88861
  Complete submission text file 0001193125-19-323073.txt   122042
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 191308370
SIC: 2834 Pharmaceutical Preparations